查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576946

Angiosuite - 市场考察，竞争情形，市场预测(～2030年)

Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023 年，全球 Angiosuite 市场规模为 21.8 亿美元，预计到 2030 年将达到 30.5 亿美元，2024-2030 年预测期间复合年增长率为 5.75%。该市场的主要推动因素包括心房颤动、週边动脉疾病（PAD）和冠状动脉疾病（CAD）等心血管疾病等慢性病患者数量的增加、主要参与者的创新产品开发活动以及老年人口的增加预计在2024年至2030 年预测期内，整个Angiosuite 市场将加速成长。

Angiosuite 市场动态

根据《世界心臟报告（2023）》提供的数据，2021年全球将有超过5亿人罹患心血管疾病。此外，根据美国心臟协会（2023）最新提供的数据，预计到2030年，全球将有超过1,200万人受到心房颤动的影响。

根据英国心臟基金会的《全球心臟和循环系统疾病情况说明书》（2024 年），全球约有 2 亿人患有 CAD。

根据美国心臟协会 (2023) 的数据，全球平均约有 2 亿人患有 PAD。此外，根据《全球疾病负担》（2019），2019年全球40至70岁的周边动脉疾病患者人数为5,640万人。

Angiosuites 对于 CAD、PAD 和心房颤动等心血管疾病的诊断和治疗至关重要。此外，AngioSuite 可用于基于导管的手术，例如心房颤动消融术以恢復正常心律。

推动 Angiosuites 市场成长的另一个主要因素是产品设计的持续技术发展，以提高 Angiosuites 市场的安全性和准确性。例如，2021年10月，印度塞康德拉巴德的雅绍达医院推出了DTAS（Direct to Angio Suite）技术，用于在中风和心臟病等神经系统紧急情况下提供快速和先进的治疗）技术。 ， "双平面神经血管手术套件" 。

世界各地监管机构增加的产品开发活动预计也将推动 angiosuite 的市场成长。例如，2022 年 5 月，飞利浦宣布其新型 MR 7700 3.0T MR 系统获得 FDA 510(k) 许可。

因此，上述所有因素共同推动了整个 Angiosuites 市场的成长。

然而，感染、血肿和血管损伤等副作用、缺乏熟练劳动力和医疗基础设施可能会对血管甜味剂市场的成长带来课题。

Angiosuites 细分市场分析

在 Angiosuite 市场的应用领域，支架类别预计将在 2023 年占据重要的收入占有率。这是由于世界各地急性中风病例所需的支架置入手术数量不断增加，以及全球中风盛行率不断上升，这与残疾和死亡等严重后果有关，Angiosuite 市场的这一领域预计将产生巨大的影响。

此外，穿戴式血管套件开发过程中发生的技术进步和产品创新可能会推动血管套件市场的成长。例如，2022年6月，西门子Healthineers推出了血管摄影系统Artis Icono，适用于支架置入、中风诊断和治疗等多种应用。该系统采用新的系统架构和 2D 和 3D 成像的影像链，具有无缝整合和第三方介面。

本报告提供全球Angiosuite市场相关调查分析，提供各地区市场规模与预测，过去3年的产品/技术开发，市场主要企业，未来的机会等资讯。

目录

第1章 Angiosuite市场报告的简介

第2章 Angiosuite市场摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 Angiosuite市场主要原因的分析

  • Angiosuite市场促进因素
  • Angiosuite市场阻碍因素与课题
  • Angiosuite市场机会

第6章 Angiosuite市场波特的五力分析

第7章 Angiosuite市场评估

  • 各类型
    • 单一平面
    • Bai平面
  • 各用途
    • 血管造影术
    • 血管成形术
    • 支架置入术
    • 绕道手术
    • 其他
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 Angiosuite市场企业与产品的简介

  • Siemens Healthineers
  • Koninklijke Philips N.V
  • Lam Vascular and Associates
  • Hitachi, Ltd.
  • ESAOTE SPA
  • IMRIS
  • Onex Corporation
  • Canon Inc.
  • 3D Systems, Inc.
  • GE HealthCare
  • Shimadzu Corporation
  • GIMIAS
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Planmeca
  • Mindray Medical International Limited
  • ZEISS International
  • Guerbet
  • Surgical Science
  • B.Braun Melsungen AG

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明，咨询方式

Product Code: DIMDCL0329

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide

The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030. The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

Angio Suites Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world.

As per data by the American Heart Association (2023), around 200 million live with PAD globally on average. Also, as per the Global Burden of Disease (2019), there were 56.4 million prevalent cases of PAD among those aged 40 to 70, worldwide in 2019.

Angio suites are vital for diagnosing and treating cardiovascular diseases like CAD, PAD, and atrial fibrillation. Moreover, angio suites can be used for catheter-based procedures like atrial fibrillation ablation to restore normal heart rhythm.

Another prominent factor responsible for the growth of the angio suites market is the constant technological developments taking place in the angio suites market for product design, and for increasing its safety and precision. For instance, in October 2021, Yashoda Hospitals, located in Secunderabad, India launched a 'Bi-Plane Neuro Angio Procedure Suite' with DTAS (Direct to Angio Suite) technology used for providing quick and highly advanced treatment in cases of brain stroke and neurological emergencies such as heart attacks.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for angio suites. For example in May 2022, Philips announced FDA 510(k) clearance for its new MR 7700 3.0T MR system, giving high performance and precision for both research and advanced clinical diagnostics.

Therefore, all the factors stated above collectively will drive the overall angio suites market growth.

However, side effects such as infections, hematoma, vessel injuries, lack of skilled workforce and medical infrastructure, and others may prove to be challenging factors for the angio suites market growth.

Angio Suites Market Segment Analysis:

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of angio suites market, the stenting category is expected to have a significant revenue share in the year 2023. This can be ascribed to an increase in stenting procedures around the world, required in acute cases of stroke, rising prevalence of stroke cases globally, leading to serious consequences like disability and death, this segment of the angio suites market is expected to generate considerable revenue.

Furthermore, technological advancements and product innovations taking place in the development of wearable angio suites are likely to propel the angio suites market growth. For instance, in June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for various applications like stenting, stroke diagnosis and treatment and others. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.

Angio suites designed for stenting procedures feature advanced imaging technologies, specialized catheterization tools, and patient monitoring systems. They are primarily used to treat CAD and PAD by placing stents to keep narrowed or blocked arteries open, thus improving blood flow and reducing the risk of heart attacks. These suites also facilitate emergency interventions for acute coronary syndromes, ensuring timely cardiovascular care.

Therefore, the widespread uses and various key features offered by stenting category, that enhance performance and usability are solidifying the impact on the growth of the overall angio suites market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall angio suites market:

Among all the regions, North America is expected to dominate the angio suites market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of CAD and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Also, according to the American Health Association (2022), Canada stands the second most to be affected by stroke globally in the year 2021.

Angio suites enable crucial diagnostic procedures like angiography to visualize coronary arteries and identify blockages. For myocardial infarction, angio suites facilitate interventions such as angioplasty and stenting to restore blood flow to the heart. Their versatility also allows for the treatment of various heart conditions, ensuring timely diagnosis and effective care.

Rising product developmental activities by regulatory bodies in the region will further boost the market for angio suites. For example, in March 2022, Philips received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its angio suite Philips Capsule Surveillance solution, paving the way for widespread deployment across healthcare systems in the US. The angio suite is capable of utilizing streaming data from virtually any connected medical device and helps in the analysis to generate actionable insights and alerts.

Additionally, in June 2022, Canon Medical Systems decided to collaborate with The Harley Street Healthcare Group Canada to launch a group of innovative diagnostic centers across Ontario. The diagnostic center is said to possess a highly equipped Angiography suite with the latest X-ray generators, Molecular Imaging, Ultrasound, and Healthcare Informatics.

Therefore, the presence of a large patient population base with heart disorders, coupled with a rise in regulatory approvals for angio suites is expected to bolster the growth of the angio suites market in the North American region during the forecast period.

Angio Suites Market key players:

Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

Recent Developmental Activities in the Angio Suites Market:

  • In June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for precise tumor embolization. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.
  • In December 2021, GE Healthcare, an auxiliary company of well-known Massachusetts, United States-based company "General Electric" announced the successful acquisition of Boston, United States-based imaging company "BK Medical".

Key Takeaways from the Angio Suites Market Report Study

  • Market size analysis for current angio suites market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the angio suites market.
  • Various opportunities available for the other competitors in the angio suites market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current angio suites market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Angio Suites Market Report Study

  • Angio suites product providers
  • Research organizations and consulting companies
  • Angio suites-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in angio suites
  • Various end-users who want to know more about the angio suites market and the latest technological developments in the angio suites market.

Frequently Asked Questions for the Angio Suites Market:

1. What are angio suites?

  • The angio suite is an examination room where complex surgical procedures like angiography, stenting, bypass surgery, etc. are performed with high precision. It helps in the detection and observation of damaged blood vessels present in different organs, helping in the diagnosis and treatment of conditions like aneurysms, vascular stenosis, coronary atherosclerosis, etc.

2. What is the market for angio suites?

  • The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030.

3. What are the drivers for the angio suites market?

  • The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the angio suites market?

  • Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

5. Which region has the highest share in the angio suites market?

North America is expected to dominate the overall angio suites market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high prevalence of coronary artery disease and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Angio Suites Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Angio Suites Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Angio Suites Market Key Factors Analysis

  • 5.1. Angio Suites Market Drivers
    • 5.1.1. Increasing cases of chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Rising geriatric population
  • 5.2. Angio Suites Market Restraints and Challenges
    • 5.2.1. Side effects such as infections, hematoma, and vessel injuries
    • 5.2.2. Lack of skilled workforce and medical infrastructure
  • 5.3. Angio Suites Market Opportunities
    • 5.3.1. Integration of AI, robotics and automation
    • 5.3.2. Increasing regulatory and research opportunities

6. Angio Suites Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Angio Suites Market Assessment

  • 7.1. By Type
    • 7.1.1. Single-plane
    • 7.1.2. Bi-plane
  • 7.2. By Application
    • 7.2.1. Angiography
    • 7.2.2. Angioplasty
    • 7.2.3. Stenting
    • 7.2.4. Bypass Surgery
    • 7.2.5. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Angio Suites Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Angio Suites Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Angio Suites Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Angio Suites Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.3. India Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Angio Suites Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Angio Suites Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Angio Suites Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Angio Suites Market Size in USD million (2021-2030)

8. Angio Suites Market Company and Product Profiles

  • 8.1. Siemens Healthineers
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Lam Vascular and Associates
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Hitachi, Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. ESAOTE SPA
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. IMRIS
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Onex Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Canon Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. 3D Systems, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. GE HealthCare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Shimadzu Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. GIMIAS
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. FUJIFILM Holdings Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Hologic, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Planmeca
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Mindray Medical International Limited
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. ZEISS International
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Guerbet
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Surgical Science
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. B.Braun Melsungen AG
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Angio Suites Market in Global (2021-2030)
  • Table 3: Angio Suites Market in Global by Type (2021-2030)
  • Table 4: Angio Suites Market in Global by Application (2021-2030)
  • Table 5: Angio Suites Market in Global by Geography (2021-2030)
  • Table 6: Angio Suites Market in North America (2021-2030)
  • Table 7: Angio Suites Market in the United States (2021-2030)
  • Table 8: Angio Suites Market in Canada (2021-2030)
  • Table 9: Angio Suites Market in Mexico (2021-2030)
  • Table 10: Angio Suites Market in Europe (2021-2030)
  • Table 11: Angio Suites Market in France (2021-2030)
  • Table 12: Angio Suites Market in Germany (2021-2030)
  • Table 13: Angio Suites Market in United Kingdom (2021-2030)
  • Table 14: Angio Suites Market in Italy (2021-2030)
  • Table 15: Angio Suites Market in Spain (2021-2030)
  • Table 16: Angio Suites Market in the Rest of Europe (2021-2030)
  • Table 17: Angio Suites Market in Asia-Pacific (2021-2030)
  • Table 18: Angio Suites Market in China (2021-2030)
  • Table 19: Angio Suites Market in Japan (2021-2030)
  • Table 20: Angio Suites Market in India (2021-2030)
  • Table 21: Angio Suites Market in Australia (2021-2030)
  • Table 22: Angio Suites Market in South Korea (2021-2030)
  • Table 23: Angio Suites Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Angio Suites Market in the Rest of the World (2021-2030)
  • Table 25: Angio Suites Market in the Middle East (2021-2030)
  • Table 26: Angio Suites Market in Africa (2021-2030)
  • Table 27: Angio Suites Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Angio Suites Market in Global (2021-2030)
  • Figure 3: Angio Suites Market in Global by Type (2021-2030)
  • Figure 4: Angio Suites Market in Global by Application (2021-2030)
  • Figure 5: Angio Suites Market in Global by Geography (2021-2030)
  • Figure 6: Angio Suites Market in North America (2021-2030)
  • Figure 7: Angio Suites Market in the United States (2021-2030)
  • Figure 8: Angio Suites Market in Canada (2021-2030)
  • Figure 9: Angio Suites Market in Mexico (2021-2030)
  • Figure 10: Angio Suites Market in Europe (2021-2030)
  • Figure 11: Angio Suites Market in France (2021-2030)
  • Figure 12: Angio Suites Market in Germany (2021-2030)
  • Figure 13: Angio Suites Market in United Kingdom (2021-2030)
  • Figure 14: Angio Suites Market in Italy (2021-2030)
  • Figure 15: Angio Suites Market in Spain (2021-2030)
  • Figure 16: Angio Suites Market in the Rest of Europe (2021-2030)
  • Figure 17: Angio Suites Market in Asia-Pacific (2021-2030)
  • Figure 18: Angio Suites Market in China (2021-2030)
  • Figure 19: Angio Suites Market in Japan (2021-2030)
  • Figure 20: Angio Suites Market in India (2021-2030)
  • Figure 21: Angio Suites Market in Australia (2021-2030)
  • Figure 22: Angio Suites Market in South Korea (2021-2030)
  • Figure 23: Angio Suites Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Angio Suites Market in the Rest of the World (2021-2030)
  • Figure 25: Angio Suites Market in the Middle East (2021-2030)
  • Figure 26: Angio Suites Market in Africa (2021-2030)
  • Figure 27: Angio Suites Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis